About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025

Advancements include CosMx® 2.0 upgrade; CosMx same-slide multiomics; and multiomics capabilities on the nCounter® platform

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for Cancer Research (AACR) General Meeting. These new advancements build upon the innovations announced at AGBT, including launch of CosMx WTX assay for subcellular spatial imaging of the whole transcriptome, the PaintScape™ platform for visualization of 3D genome architecture and chromosomal structure in single cells, the PowerOMX™ engine for streamlined spatial proteomics analysis on the CellScape™ platform, and the 1,200-plex protein panel for GeoMx® DSP. Bruker Spatial Biology today announces the following innovations that underscore Bruker’s leading commitment to advancing spatial biology with pioneering, best-in-class platforms.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425045849/en/

Spatial pathway and transcript overlay in AtoMx Analysis Suite from CosMx WTX pancreas data

Spatial pathway and transcript overlay in AtoMx Analysis Suite from CosMx WTX pancreas data

CosMx 2.0 Advancements for Unmatched Performance

Available later this quarter, the commercial CosMx SMI and AtoMx® SIP platforms will be upgraded to an integrated 2.0 software. Following this upgrade, commercial CosMx SMI instruments will deliver up to a 2X increase in RNA detection efficiency across all commercial RNA assays and enable the whole transcriptome in advance of commercial assay shipments this summer. Additionally, the AtoMx spatial informatics platform will house new Bruker-trained AI cell segmentation models, extending the platform’s best-in-class definition of single-cell boundaries for accurate transcript assignment. Together, these advancements deliver unmatched performance for high fidelity single-cell spatial transcriptomics, enabling deeper insights into intratumor heterogeneity, immune cell infiltration, and pathway dysregulation within the tumor microenvironment.

“By imaging the whole transcriptome at the individual transcript level and advancing sensitivity across any in situ RNA assay, these developments in CosMx represent a historic milestone in the study of spatial biology," said Dr. William Hwang, M.D., Ph.D, Assistant Professor at Harvard Medical School.

Bruker will begin taking advance orders in May for the CosMx Whole Transcriptome (WTX) assay, ahead of commercial shipments this summer.

The CosMx 2.0 update will also unlock the same-slide multiomics feature on the platform in advance of the assay workflow, which will be commercially available in the second half of 2025. Same-slide multiomics will empower oncology researchers to simultaneously analyze the whole transcriptome (~19,000 targets) and immuno-oncology related proteins (up to 76 proteins) within the same cell, providing a comprehensive view of cellular phenotypes, pathway biology, and disease mechanisms with complete spatial context.

nCounter Platform to Offer Multiomic Assays

Bruker is introducing new multiomic capabilities for the nCounter platform, enabling first-to-market, bulk measurement of RNA and protein from the same sample, including FFPE, in a single run on the same platform. This evolution builds on nCounter’s proven track record in gene expression analysis and expands its utility with the addition of nCounter Immune Pathways Protein and nCounter Tumor Signaling Protein panels.

With the addition of nCounter Protein panels, the nCounter platform now pairs high-plex protein panels (200 – 300 targets) with its established nCounter RNA panels to deliver true, single-run multiomics from both FFPE and fresh frozen samples. The nCounter Protein panels will offer a stackable design to support tailoring assays for specific research questions and tumor types. A streamlined, 3-day sample-to-answer multiomic workflow minimizes delays in critical studies, while integrated data analysis simplifies multiomic harmonization and enables intuitive visualization of RNA and protein expression — accelerating translational studies without added complexity.

nCounter Multiomics with the nCounter Immune Pathways Protein panel and nCounter Tumor Signaling Protein panel will be available commercially in the second half of 2025 and is currently accessible through a Technology Access Program.

Join Bruker at AACR 2025

Bruker Spatial Biology will be at booth #2320 at the AACR General Meeting and will share more details on these innovations in their spotlight theater on Tuesday, April 29 at 3:00PM CT titled “Expanding the Limits of Spatial Biology: Comprehensive Integrated Technologies for Spatial Multiomics”. Demonstrations of the entire suite of Bruker Spatial Biology platforms including CosMx, GeoMx, CellScape, and PaintScape in addition to the nCounter will showcase the transformative potential of these technologies.

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

Contacts

Investor Contact:

Joe Kostka

Director, Investor Relations

Bruker Corporation

T: +1 (978) 313-5800

E: Investor.Relations@bruker.com

Media Contact:

Johnny Lyssand

Director, Downstream Marketing

Bruker Spatial Biology

T: +1 (206) 790-2843

E: john.lyssand@bruker.com

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.03
+0.00 (0.00%)
AAPL  262.77
+0.00 (0.00%)
AMD  238.03
+0.00 (0.00%)
BAC  51.52
+0.00 (0.00%)
GOOG  251.34
+0.00 (0.00%)
META  733.27
+0.00 (0.00%)
MSFT  517.66
+0.00 (0.00%)
NVDA  181.16
+0.00 (0.00%)
ORCL  275.15
+0.00 (0.00%)
TSLA  442.60
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.